Synopsys to Report Q1 Earnings: What's in the Cards for the Stock?
Werte in diesem Artikel
Synopsys SNPS is scheduled to report first-quarter fiscal 2025 results on Feb. 26, after market close.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Synopsys expects non-GAAP earnings per share between $2.77 and $2.82. The Zacks Consensus Estimate for fiscal first-quarter earnings is pinned at $2.81 per share, which indicates a year-over-year decline of 21%.The company anticipates revenues between $1.435 billion and $1.465 billion for the fiscal first quarter. The Zacks Consensus Estimate is pegged at $1.45 billion, which suggests a decline of 11.9% from the year-ago period's reported figure.In the trailing four quarters, SNPS’ earnings surpassed the Zacks Consensus Estimate thrice while missing the same on one occasion, with an average surprise of 2.68%.Synopsys, Inc. Price and EPS Surprise Synopsys, Inc. price-eps-surprise | Synopsys, Inc. QuoteFactors Influencing Synopsys’ Q1 ResultsSynopsys’ fiscal first-quarter performance is likely to have benefited from the rising demand for its extensive product portfolio. The growing need for high-performance cloud computing, propelled by the evolving hybrid work environment, is expected to have boosted demand for the company's Intellectual Property (IP) solutions.Increased adoption of Synopsys.ai among chip manufacturers and vendors is anticipated to have boosted top-line growth during the reported quarter. Additionally, the long-term collaboration with TSMC aimed to deliver advanced EDA and IP solutions on TSMC’s most advanced process and 3DFabric technologies to accelerate innovation for AI and multi-die designs is expected to have been a major positive.The surge in global design activity and heightened user engagement are expected to have significantly driven SNPS’ performance in the fiscal first quarter. Growing adoption of its interface and foundation IP solutions, along with contract wins and the use of the Fusion Platform, including the Fusion Compiler, is anticipated to have positively impacted SNPS’ fiscal first-quarter performance.The increasing use of AI, IoT, 5G and cloud technology is likely to have driven demand for Synopsys’ solutions in the to-be-reported quarter. Additionally, robust design investments in Synopsys’ ARC processors by automotive companies, as well as the strong adoption of security solutions for interfaces like CXL, PCI Express and DDR, are likely to aid its first-quarter results.However, tightening budgets among corporations due to ongoing macroeconomic challenges and unfavorable currency exchange rates are expected to have partially offset the positive impacts of the growth drivers.What Our Model Says About SNPSOur proven model does not conclusively predict an earnings beat for SNPS this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that’s not the case here.Though SNPS currently carries a Zacks Rank #3, it has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.Stocks With Favorable CombinationMarvell Technology MRVL, ODDITY ODD and IonQ IONQ are some stocks that have a favorable combination.Marvell Technology has an Earnings ESP of +2.77% and a Zacks Rank #2 at present. MRVL shares have gained 51.3% in the trailing 12-month period. MRVL is set to report its fourth-quarter 2024 results on March 5. You can see the complete list of today’s Zacks #1 Rank stocks here.ODDITY has an Earnings ESP of +4.00% and a Zacks Rank #3 at present. ODD shares have rallied 9.9% in the trailing 12-month period. ODD is slated to report its fourth-quarter 2024 results on Feb. 25.IonQ has an Earnings ESP of +35.14% and a Zacks Rank #3 at present. IONQ shares have gained 182.4% in the trailing 12-month period. IONQ is scheduled to report its fourth-quarter 2024 results on Feb. 26.Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Marvell Technology, Inc. (MRVL): Free Stock Analysis Report Synopsys, Inc. (SNPS): Free Stock Analysis Report IonQ, Inc. (IONQ): Free Stock Analysis Report ODDITY Tech Ltd. (ODD): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Synopsys und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Synopsys
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Synopsys
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Synopsys Inc.
Analysen zu Synopsys Inc.
Datum | Rating | Analyst | |
---|---|---|---|
22.08.2019 | Synopsys Buy | Needham & Company, LLC | |
03.04.2019 | Synopsys Buy | Needham & Company, LLC | |
28.03.2019 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | The Benchmark Company |
Datum | Rating | Analyst | |
---|---|---|---|
22.08.2019 | Synopsys Buy | Needham & Company, LLC | |
03.04.2019 | Synopsys Buy | Needham & Company, LLC | |
28.03.2019 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | The Benchmark Company |
Datum | Rating | Analyst | |
---|---|---|---|
09.09.2015 | Synopsys Hold | The Benchmark Company | |
04.12.2008 | Synopsys Upgrade | Citigroup Corp. | |
02.02.2007 | Synopsys neutral | DA Davidson | |
31.01.2007 | Update Synopsys Inc.: Neutral | DA Davidson | |
30.11.2006 | Synopsys hold | Deutsche Securities |
Datum | Rating | Analyst | |
---|---|---|---|
21.08.2008 | Synopsys Downgrade | Citigroup Corp. | |
24.06.2005 | Synopsys underweight | Prudential Financial |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen